OTCMGBNHF
Market cap456kUSD
Dec 23, Last price
0.01USD
1D
-25.65%
1Q
14.94%
IPO
-99.91%
Name
Greenbrook Tms Inc
Chart & Performance
P/E
—
P/S
0.01
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
25.36%
Rev. gr., 5y
38.06%
Revenues
69m
+32.39%
Net income
-87m
L+193.81%
CFO
-13m
L-19.14%
Profile
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||
Revenues | 69,104 32.39% | 52,198 21.03% | ||||||
Cost of revenue | 88,314 | 68,620 | ||||||
Unusual Expense (Income) | ||||||||
NOPBT | (19,209) | (16,422) | ||||||
NOPBT Margin | ||||||||
Operating Taxes | 24,289 | 4,653 | ||||||
Tax Rate | ||||||||
NOPAT | (43,498) | (21,075) | ||||||
Net income | (86,713) 193.81% | (29,513) -9.11% | ||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 35,108 | |||||||
BB yield | -53.78% | |||||||
| Debt | ||||||||
Debt current | 13,641 | 7,157 | ||||||
Long-term debt | 146,821 | 68,562 | ||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | 158,838 | 65,020 | ||||||
| Cash flow | ||||||||
Cash from operating activities | (13,211) | (16,339) | ||||||
CAPEX | (34) | (32) | ||||||
Cash from investing activities | 167 | (15,138) | ||||||
Cash from financing activities | 3,968 | 24,420 | ||||||
FCF | (60,356) | (26,828) | ||||||
| Balance | ||||||||
Cash | 1,624 | 10,700 | ||||||
Long term investments | ||||||||
Excess cash | 8,090 | |||||||
Stockholders' equity | (35,148) | 12,385 | ||||||
Invested Capital | 112,088 | 53,185 | ||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | 23,236 | 15,470 | ||||||
Price | 1.93 -54.27% | 4.22 -56.68% | ||||||
Market cap | 44,845 -31.31% | 65,282 -47.64% | ||||||
EV | 201,430 | 129,563 | ||||||
EBITDA | (9,693) | (10,028) | ||||||
EV/EBITDA | ||||||||
Interest | 8,724 | 4,761 | ||||||
Interest/NOPBT | ||||||||